Our results revealed that treatment of SK‐OV‐3 cells, epithelial human ovarian carcinoma, with these resveratrol analogues (10 μM, 24 h) led to differential expression of RAD51 (Figure 1C,D). Here, RAD51 is linked to ovarian carcinoma.